The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Xu J, Corona K, Chamoun K, Shah J, Canales M, Maerevoet M

Open source

DOI: 10.3390/cancers14030791
Published: 2022 Feb 4
Container: Cancers
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers14030791,
  title = {The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.},
  author = {Zijlstra JM and Follows G and Casasnovas RO and Vermaat JSP and Kalakonda N and Choquet S and Hill B and Thieblemont C and Cavallo F and Cruz F and Kuruvilla J and Hamad N and Jaeger U and Caimi P and Gurion R and Warzocha K and Bakhshi S and Sancho JM and Schuster M and Egyed M and Offner F and Vassilakopoulos TP and Samal P and Ku M and Xu J and Corona K and Chamoun K and Shah J and Canales M and Maerevoet M},
  year = {2022},
  journal = {Cancers},
  doi = {10.3390/cancers14030791},
  url = {https://doi.org/10.3390/cancers14030791}
}

RIS

TY  - JOUR
TI  - The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.
AU  - Zijlstra JM
AU  - Follows G
AU  - Casasnovas RO
AU  - Vermaat JSP
AU  - Kalakonda N
AU  - Choquet S
AU  - Hill B
AU  - Thieblemont C
AU  - Cavallo F
AU  - Cruz F
AU  - Kuruvilla J
AU  - Hamad N
AU  - Jaeger U
AU  - Caimi P
AU  - Gurion R
AU  - Warzocha K
AU  - Bakhshi S
AU  - Sancho JM
AU  - Schuster M
AU  - Egyed M
AU  - Offner F
AU  - Vassilakopoulos TP
AU  - Samal P
AU  - Ku M
AU  - Xu J
AU  - Corona K
AU  - Chamoun K
AU  - Shah J
AU  - Canales M
AU  - Maerevoet M
PY  - 2022
JO  - Cancers
DO  - 10.3390/cancers14030791
UR  - https://doi.org/10.3390/cancers14030791
ER  -

APA

JM, Z., G, F., RO, C., JSP, V., N, K., S, C., B, H., C, T., F, C., F, C., J, K., N, H., U, J., P, C., R, G., K, W., S, B., JM, S., M, S., M, E., F, O., TP, V., P, S., M, K., J, X., K, C., K, C., J, S., M, C., & M, M. (2022). The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.. Cancers. https://doi.org/10.3390/cancers14030791

Source records

pubmed · retrieved 2026-09-27T09:54:43.818Z